Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
Wei‐Feng Qu(Ministry of Education of the People's Republic of China), Ying–Hong Shi(Ministry of Education of the People's Republic of China), Pei‐Yun Zhou(Fudan University), Wei‐Ren Liu(Chung Yuan Christian University), Yuan Fang(First Hospital of Qinhuangdao), Zheng Tang(Nanjing University of Science and Technology), Shuang–Jian Qiu(Fudan University), Jia Fan(Nanjing Tech University), Lei Jin(Air Force Medical University), Han Wang(Fudan University), Jian Zhou(Fudan University), Shushu Song(Fudan University), Meng‐Xin Tian(Sun Yat-sen University), Chen-Yang Tao(Fudan University), Zhi Dai(Ministry of Education of the People's Republic of China), Xi‐Fei Jiang(Sun Yat-sen University), Zhen‐Bin Ding(Fudan University), Yufu Zhou(Central South University), Yuan‐Fei Peng(Fudan University)
Cited by 49
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828